r*e
2 楼
随便查一下就有新闻
Shares of Intercept Pharmaceuticals (NASDAQ: ICPT) jumped in premarket
trading yesterday after the company announced relatively positive results
from a long-running clinical trial. A closer look at the top-line results,
though, left investors with a lot of important questions about safety
signals. As a result, the stock lost 15.8% on Wednesday.
[在 huhu1 (呼呼~) 的大作中提到：]
:？
Shares of Intercept Pharmaceuticals (NASDAQ: ICPT) jumped in premarket
trading yesterday after the company announced relatively positive results
from a long-running clinical trial. A closer look at the top-line results,
though, left investors with a lot of important questions about safety
signals. As a result, the stock lost 15.8% on Wednesday.
[在 huhu1 (呼呼~) 的大作中提到：]
:？
相关阅读